AGs Push High Court To Hear Pay-For-Delay Drug Suit

Law360, New York (January 7, 2011, 7:54 PM EST) -- Attorneys general from 32 states urged the U.S. Supreme Court Friday to take up a case on the legality of so-called pay-for-delay agreements in which brand-name drug companies pay generics manufacturers to keep their cheaper drugs off the market.

The attorneys general, led by newly elected California Attorney General Kamala D. Harris, told the high court that the pay-for-delay agreements violated antitrust law and thwarted the aims of the Drug Price Competition and Patent Term Restoration Act of 1984, which was designed to encourage the speedy...
To view the full article, register now.